Torrent Pharmaceuticals has received approval from Securities Transfer and Stakeholders Relationship Committee (STSRC) for issuance of Secured, Rated, Listed, Redeemable Non-Convertible Debentures (NCDs) aggregating upto Rs 12,500 crore in one or more tranches on private placement basis.
Securities Transfer and Stakeholders Relationship Committee (STSRC) has at its meeting held on January 05, 2026 has approved the same.
Torrent Pharmaceuticals (Torrent Pharma) is flagship company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.
